MARK A. GOLDSMITH - 18 Dec 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
18 Dec 2024
Net transactions value
+$15,115
Form type
4
Filing time
20 Dec 2024, 16:50:14 UTC
Previous filing
18 Dec 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $15,115 +30,846 +9.5% $0.4900 355,902 18 Dec 2024 Direct F1
holding RVMD Common Stock 20,424 18 Dec 2024 Trust F2
holding RVMD Common Stock 20,424 18 Dec 2024 Trust F3
holding RVMD Common Stock 465,604 18 Dec 2024 Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -30,846 -100% $0.000000 0 18 Dec 2024 Common Stock 30,846 $0.4900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 167,125 restricted stock units.
F2 Held by Jonathan Goldsmith Revocable Trust.
F3 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F4 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.

Remarks:

President and Chief Executive Officer